Approval · Notice of Compliance 2461 · 2001
NUBAIN: Notice of Compliance 2461
Issued December 4, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2461
- Date
- December 4, 2001
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Opioid analgesic
Products in this notice
Medicinal ingredients
- NALBUPHINE HYDROCHLORIDE 10 MG per ML
- NALBUPHINE HYDROCHLORIDE 20 MG per ML